Dr. Raichlen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Hoffman Dr
Bryn Mawr, PA 19010Phone+1 610-525-5004
Education & Training
- Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1980 - 1982
- Temple University HospitalResidency, Internal Medicine, 1977 - 1980
- Perelman School of Medicine at the University of PennsylvaniaClass of 1977
Certifications & Licensure
- PA State Medical License 1979 - 2024
- NJ State Medical License 1998 - 2011
- DE State Medical License 1997 - 2009
- NY State Medical License 1998 - 2009
- DC State Medical License 2003 - 2008
- OH State Medical License 1998 - 2008
- VA State Medical License 1997 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FAHA) American Heart Association
- Fellow (FACP) American College of Physicians
- Fellow (FACC) American College of Cardiology
Clinical Trials
Publications & Presentations
PubMed
- 540 citationsEffect of Two Intensive Statin Regimens on Progression of Coronary DiseaseStephen J. Nicholls, Christie M. Ballantyne, Philip J. Barter, M. John Chapman, Raimund Erbel
The New England Journal of Medicine. 2011-11-30 - 57 citationsFactors underlying regression of coronary atheroma with potent statin therapyRishi Puri, Steven E. Nissen, Christie M. Ballantyne, Phillip J. Barter, M. John Chapman
European Heart Journal. 2013-06-21 - 1452 citationsEffect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.Steven E. Nissen, Stephen J. Nicholls, Ilke Sipahi, Peter Libby, Joel S. Raichlen
JAMA. 2006-04-05
Authored Content
- LDL Extracellular Vesicle Coagulation Protein Levels Change After Initiation of Statin Therapy. Findings from the METEOR TrialMay 2018
Professional Memberships
- Fellow
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: